Contact the publisher of this press release

SignaBlok to Present Preclinical Data on TREM-1-Targeting Drug for the Treatment of Cancer at the American Association for Cancer Research (AACR) Annual Meeting 2025

Your message has been sent.
There were problems with your form submission